Similarly, the difference in size between (m)anti-MMR Nbs and (biv)anti-MMR Nbs influences their targeting capability: in fact, both in healthy and tumor tissue, (m)anti-MMR Nbs showed a faster kinetic of macrophage targeting compared to (biv)anti-MMR Nbs. This evidence concerns the gene MRC1 and neoplasm.